3 Dividend Stocks That Don’t Need a Booming Economy to Keep Paying

Published November 16, 2026, 9:47am ET · 5 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A worker in a hard hat and high-visibility vest standing and looking at the camera
© vm / Getty Images

A slowdown tests a dividend by squeezing the cash behind it. These three payers sell products and services people keep buying in a weak economy: Medtronic (NYSE:MDT | MDT Price Prediction) makes heart and spine devices, Northrop Grumman (NYSE:NOC) builds bombers and missiles, and Republic Services (NYSE:RSG) collects trash. Their yields are modest, but they share a dividend that kept growing the last time the economy stopped. Each one raised its quarterly payout in 2020, the year of the pandemic shutdown.

Medtronic: Hospitals Keep Booking Procedures in Any Economy

Medtronic pays $0.72 a quarter, or $2.88 a year. At the latest price of $102.88, that works out to a forward yield of about 2.80%, the highest of the three.

Demand holds up because a failing heart rhythm or a collapsed spinal disc cannot wait for a recovery. In its most recent quarter, the company’s finance chief pointed to “healthy underlying procedure volumes across nearly all of our end markets and geographies.”[1] First-quarter fiscal 2027 revenue rose 13.7%[2] to $9.756B. Management estimated that an extra selling week added about $570 million. Cardiac Ablation Solutions grew 88%[2].

Dividend safety: Free cash flow covers the payout. In the quarter, Medtronic generated $1.29B[2] of free cash flow and paid $921M in dividends, about 71% of that cash. For the full fiscal 2026, free cash flow was $5.426B[3], while the current annual dividend costs roughly $3.68B. On earnings, the payout is about 70% of trailing GAAP EPS of $4.07. Measured against the low end of fiscal 2027 non-GAAP EPS guidance of $5.94[2], it drops to about 48%. The CFO described the balance sheet as “strong”[1] with “a lot of firepower” for investment.

Track record: Medtronic says its latest raise marked the 49th consecutive year of dividend increases[3]. That streak runs through both the 2008 financial crisis and the pandemic. Its dividend history shows the quarterly payout rising from $0.54 to $0.58 across the 2020 period.

Bull case: You get a payout close to 3% from a company that just raised fiscal 2027 organic growth guidance to 7.25% to 7.75%[2]. The stock trades at a forward P/E of 17, compared with a trailing 25, and its beta of 0.568 points to below-market volatility.

Risk: Dividend growth is slow. The most recent raise lifted the quarterly payout from $0.71 to $0.72. With the payout near 70% of GAAP earnings and the MiniMed diabetes separation still underway, income growth here is likely to stay modest.

Northrop Grumman: A Record Backlog Funds the Check

Northrop Grumman pays $2.47 a quarter, or $9.88 annualized. That’s a forward yield of about 1.79% at $550.72.

Demand depends on defense budgets and multiyear contracts, which move independently of consumer spending. Backlog reached a record $109.6B[4] in the third quarter, up 15% from year-end 2025, on a 1.5x book-to-bill. The Pentagon’s fiscal 2027 request includes $6,108.7 million for the B-21 Raider, with Northrop listed as prime contractor. It also seeks $87.2 billion for sea power, including two Virginia-class submarines. Northrop’s CEO said the company is “relatively insulated from incremental funding uncertainty.”[5]

Dividend safety: This is the most conservatively covered dividend of the three. The annual payout costs about $1.40B, against 2026 adjusted free cash flow guidance of $3.1B to $3.5B[4]. The 2027 outlook calls for $3.3 billion to $3.7 billion[5] of adjusted free cash flow, while capex falls to about $2.1 billion. The dividend takes about 30% of trailing EPS of $31.68. Against the low end of 2026 MTM-adjusted EPS guidance, $29.35[4], it takes about 34%. Buybacks totaled only $68M[4] year to date, so Northrop is keeping cash for B-21 capacity and the dividend.

Track record: The dividend history shows a raise in every year from 2009 through 2026. In the depths of the Great Recession, the quarterly payout rose from $0.40 to $0.43. In 2020, it rose from $1.32 to $1.45. The latest increase took it from $2.31 to $2.47.

Bull case: Income investors get steady dividend raises backed by revenue already under contract. The stock trades well below its 52-week high of $767.12 and is down 2.27% year to date. Analysts’ average target is $635.25. A beta of -0.136 means the shares have moved largely independently of the broader market.

Risk: Funding timing matters. Northrop is operating under a continuing resolution, and management named the “level and timing of appropriations”[5] as a factor in where 2027 growth lands within its 5% to 7% sales outlook.

Republic Services: Trash Pickup Runs on Every Economic Cycle

Republic Services pays $0.67 a quarter, or $2.68 annualized. That’s a forward yield of about 1.06% at $253.05. The yield is the lowest here, but the payout grows quickly: the latest raise added $0.045[6], roughly 7%.

Republic is the second largest U.S. provider of non-hazardous solid waste services, and its customers rarely leave. CEO Jon Vander Ark said, “Customer retention remained high at more than 94%.”[7] Core price added 5.3% to total revenue in the third quarter. He added that “average yield on related revenues is 3.5% and continues to exceed our internal cost inflation.”[7]

Dividend safety: Year-to-date, dividends totaled $577 million[7] against $2.28 billion of adjusted free cash flow, about 25%. Full-year adjusted free cash flow guidance rose to $2.565B to $2.585B. The trailing payout is about 35% of EPS of $7.22. Total debt is about $14.2 billion[7] at roughly 2.6x leverage, with $2.3 billion of liquidity.

Track record: During the Great Recession, Republic held its quarterly dividend at $0.19 from 2009-03-30 through 2010-12-30 without a cut, then raised it to $0.20 in 2011. In the 2020 shutdown, it raised the payout from $0.405 to $0.425, declared 2020-07-29.

Bull case: Pricing that outpaces costs, plus a new $5.0B buyback authorization running through 2029, gives Republic room to keep raising the dividend. Environmental Solutions’ adjusted EBITDA margin expanded to 25.4% from 21.0%. Management expects AI routing and pricing tools to add $100 million[7] of run-rate EBITDA by the end of 2028.

Risk: You pay a premium for that stability. The stock trades at a trailing P/E of 35 and a forward P/E of 32, close to its 52-week high of $255.39 after a 24.26% one-year gain. A yield near 1% offers little cushion if that multiple compresses.

Three Paychecks Built for a Slowdown

Medtronic offers the most current income, Northrop the strongest coverage, and Republic the fastest dividend growth. All three fund their payouts from demand set by surgeons, defense appropriations, and municipal trash routes. Each kept its dividend intact through the last two downturns, and each covers today’s payout comfortably with free cash flow. If you want income that doesn’t depend on a strong economy, these three come with track records you can check.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →

Sources

  1. Medtronic plc Q1 2027 earnings callMedtronic plc
  2. Medtronic plc. Form 8-K (Q1 FY2027)U.S. Securities and Exchange Commission
  3. Medtronic plc. Form 8-K (Q4 FY2026)U.S. Securities and Exchange Commission
  4. Northrop Grumman Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  5. Northrop Grumman Corporation Q3 2026 earnings callNorthrop Grumman Corporation
  6. Republic Services Form 8-K (Q2 FY2026)U.S. Securities and Exchange Commission
  7. Republic Services, Inc. Q3 2026 earnings callRepublic Services, Inc.